tiprankstipranks
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
US Market
IONS
Ionis Pharmaceuticals
RESEARCH TOOLSreports

Ionis Pharmaceuticals (IONS) Stock News & Sentiment

1,487 Followers
Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors
Premium
Company Announcements
Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors
4d ago
IONS
Ionis: Olezarsen’s Expanded Global Opportunity and Strengthened Royalty Streams Support Reiterated Buy and $120 Target
Premium
Ratings
Ionis: Olezarsen’s Expanded Global Opportunity and Strengthened Royalty Streams Support Reiterated Buy and $120 Target
11d ago
IONS
Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS
Premium
Market News
Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS
29d ago
TEM
TXG
Ionis Pharmaceuticals Announces Board Retirements and New Appointment
Premium
Company Announcements
Ionis Pharmaceuticals Announces Board Retirements and New Appointment
1M ago
8K
IONS
Ionis Pharmaceuticals Earnings Call Highlights Surging Momentum
Premium
Company Announcements
Ionis Pharmaceuticals Earnings Call Highlights Surging Momentum
1M ago
IONS
Ionis Pharmaceuticals: Accelerating Commercial Momentum, Conservative Guidance, and Late-Stage Pipeline Catalysts Underpin Buy Rating
Premium
Ratings
Ionis Pharmaceuticals: Accelerating Commercial Momentum, Conservative Guidance, and Late-Stage Pipeline Catalysts Underpin Buy Rating
1M ago
IONS
Ionis Pharmaceuticals: Strong 4Q25 Beat and Catalyst-Rich 2026 Underpin Raised Buy Rating and $103 Target
Premium
Ratings
Ionis Pharmaceuticals: Strong 4Q25 Beat and Catalyst-Rich 2026 Underpin Raised Buy Rating and $103 Target
1M ago
IONS
More IONS News >

IONS News on the Web

Nike downgraded, IBM initiated: Wall Street’s top analyst calls
TipRanks News
Bullish
Ionis Pharmaceuticals resumed with an Outperform at Raymond James
TipRanks News
Neutral
CNBC Cures: A father and a doctor on how raising a child with Angelman syndrome changed him
CNBC
Neutral
Ionis Pharmaceuticals price target raised to $111 from $100 at BofA
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: EDAP TMS (EDAP), Ionis Pharmaceuticals (IONS)
TipRanks News
Neutral
Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Corbus Pharmaceuticals (CRBP) and Artivion (AORT)
TipRanks News
Neutral
Insider Sell Alert: Shannon Devers Sells Shares of Ionis Pharmaceuticals Inc (IONS)
GuruFocus News
Neutral

News Score - Last 7 Days

Positive
IONS
Sector Average
Media Buzz
This Week7 articles
Weekly Average9.25 articles
News Sentiment
This Week100%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IONS’s Media Buzz Sentiment?
7 articles about IONS were published this week. In an average week, 9.25 articles are published.
    What is IONS’s weekly average amount of articles?
    In an average week, 9.25 articles about IONS are published.
      What is IONS’s News Sentiment?
      100% of articles about IONS were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        SZYCFSaizeriya Co
        PAYPPayPay Corporation
        0RJIAnheuser Busch InBev SA/NV
        ENWEnwave Corp
        ZDCZedcor Energy Inc
        Showing the stocks with the most bullish news sentiment over the past week